Reference
Pollack A. Biotech Firms, Billions at Risk, Lobby States to Limit Generics.Internet Document : 28 Jan 2013. Available from: URL: http://www.nytimes.com
Rights and permissions
About this article
Cite this article
Biotech firms lobby states to limit generic competition in USA. PharmacoEcon Outcomes News 671, 1 (2013). https://doi.org/10.1007/s40274-013-0115-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0115-1